论文部分内容阅读
目的:观察雾化吸入爱喘乐(溴化异丙阿托品)与博利康尼治疗婴幼儿哮喘急性发作的临床疗效。方法将128例6个月至3岁哮喘患儿随机分成两组。治疗组通过氧动力雾化吸入爱喘乐与博利康尼混合液,对照组给予普米克气雾剂和喘康速气雾剂吸入。结果临床治疗组:显效64.8%,有效28.1%,总有效率治疗组92.9%;对照组显效40.4%,有效40.4%,总有效率80.8%;治疗组总有效率高于对照组总有效率,P<0.05。结论爱喘乐和博利康尼雾化液吸入治疗婴幼儿哮喘急性发作疗效显著、安全。
Objective: To observe the clinical efficacy of inhalation of Atrazole (Brominated Isoproturon Bromide) and Boli Kang Ni in the treatment of infant acute asthma attack. Methods 128 children aged 6 months to 3 years old were randomly divided into two groups. The treatment group inhaled the mixture of Astrazolin and Boracic acid by aerodynamic atomization, and the control group inhaled Pulmicort Aerosol and Chuan Kang Aerosol. Results In the clinical treatment group, the effective rate was 64.8%, the effective rate was 28.1%, the total effective rate was 92.9% in the treatment group; the effective rate in the control group was 40.4%, the effective rate was 40.4% and the total effective rate was 80.8%; the total effective rate in the treatment group was higher than that in the control group, P <0.05. Conclusion Atrazole and Boli Kang Ni inhalation of asthma in infants and young children with acute attack of significant and safe.